⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8183850 | 0.76 | — | — | |
| SCHEMBL2006067 | 0.76 | — | — | |
| SCHEMBL16508915 | 0.71 | — | — | |
| SCHEMBL2673476 | 0.71 | — | — | |
| SCHEMBL2367442 | 0.71 | — | — | |
| SCHEMBL24874217 | 0.71 | — | — | |
| SCHEMBL15478600 | 0.71 | — | — | |
| SCHEMBL23153772 | 0.71 | — | — | |
| SCHEMBL5512862 | 0.71 | — | — | |
| SCHEMBL7347165 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109310756-B | Novel angiopoietin 2, VEGF bispecific antagonists | 奥美药业有限公司 | 2022-06-28 | — | — | CN | disclosed |
| CN-109414500-B | PD-L1 specific monoclonal antibody for treatment and diagnosis | 奥美药业有限公司 | 2022-02-25 | — | — | CN | disclosed |
| EP-2347762-B1 | EXENDIN FOR TREATING DIABETES AND REDUCING BODY WEIGHT | AMYLIN PHARMACEUTICALS LLC (US) | 2019-05-08 | — | — | EP | disclosed |
| EP-2303313-B1 | EXENDINS TO LOWER CHOLESTROL AND TRIGLYCERIDES | AMYLIN PHARMACEUTICALS LLC (US) | 2015-10-28 | — | — | EP | disclosed |
| EP-1971362-B1 | EXENDIN FOR TREATING DIABETES AND REDUCING BODY WEIGHT | AMYLIN PHARMACEUTICALS LLC (US) | 2014-12-03 | — | — | EP | disclosed |
| US-5985869-A | USEFUL AS VASODILATORS, HYPOTENSIVE AGENTS, WATER DIURETICS, PLATELET AGGLUTINATION INHIBITORS | OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) | 1999-11-16 | — | — | US | disclosed |
| US-5753677-A | Benzoheterocyclic compounds | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1998-05-19 | — | — | US | disclosed |
| US-5559230-A | VASOPRESSIN ANTAGONISTS, QUINOLINES, BENZAZEPINES, VASODILATION, HYPOTENSIVE AGENTS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1996-09-24 | — | — | US | disclosed |
| US-5521179-A | Heterocyclic amides | ZENECA LIMITED (GB) | 1996-05-28 | — | — | US | disclosed |
| EP-0450097-B1 | BENZOHETEROCYCLIC COMPOUNDS | OTSUKA PHARMA CO LTD (JP) | 1996-04-24 | — | — | EP | disclosed |
| EP-0663834-A4 | GROWTH HORMONE RELEASING PEPTIDES. | SMITHKLINE BEECHAM CORP (US) | 1996-01-24 | — | — | EP | disclosed |
| EP-0663834-A1 | GROWTH HORMONE RELEASING PEPTIDES | SMITHKLINE BEECHAM CORPORATION (US) | 1995-07-26 | — | — | EP | disclosed |
| EP-0602209-A1 | OXYTOCIN ANTAGONIST | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1994-06-22 | — | — | EP | disclosed |
| WO-1994007519-A1 | GROWTH HORMONE RELEASING PEPTIDES | SMITHKLINE BEECHAM CORPORATION (US) | 1994-04-14 | — | — | WO | disclosed |
| WO-1994001113-A1 | OXYTOCIN ANTAGONIST | OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) | 1994-01-20 | — | — | WO | disclosed |
| EP-0450097-A1 | BENZOHETEROCYCLIC COMPOUNDS. | OTSUKA PHARMA CO LTD (JP) | 1991-10-09 | — | — | EP | disclosed |
| WO-1991005549-A1 | BENZOHETEROCYCLIC COMPOUNDS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1991-05-02 | — | — | WO | disclosed |
| EP-0074229-A1 | Triazole gastric anti-secretory agents | PFIZER INC. (US) | 1983-03-16 | — | — | EP | disclosed |